Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Induction of EMT-like response by BMP4 via up-regulation of lysyl oxidase is required for adipocyte lineage commitment.

Huang HY, Chen SZ, Zhang WT, Wang SS, Liu Y, Li X, Sun X, Li YM, Wen B, Lei QY, Tang QQ.

Stem Cell Res. 2013 May;10(3):278-87. doi: 10.1016/j.scr.2012.12.005. Epub 2013 Jan 5.

2.

Involvement of cytoskeleton-associated proteins in the commitment of C3H10T1/2 pluripotent stem cells to adipocyte lineage induced by BMP2/4.

Huang HY, Hu LL, Song TJ, Li X, He Q, Sun X, Li YM, Lu HJ, Yang PY, Tang QQ.

Mol Cell Proteomics. 2011 Jan;10(1):M110.002691. doi: 10.1074/mcp.M110.002691. Epub 2010 Aug 16.

3.

BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage.

Huang H, Song TJ, Li X, Hu L, He Q, Liu M, Lane MD, Tang QQ.

Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12670-5. doi: 10.1073/pnas.0906266106. Epub 2009 Jul 20.

4.

miR-27 impairs the adipogenic lineage commitment via targeting lysyl oxidase.

Chen SZ, Xu X, Ning LF, Jiang WY, Xing C, Tang QQ, Huang HY.

Obesity (Silver Spring). 2015 Dec;23(12):2445-53. doi: 10.1002/oby.21319. Epub 2015 Nov 5.

5.

RhoGDIβ Inhibits Bone Morphogenetic Protein 4 (BMP4)-induced Adipocyte Lineage Commitment and Favors Smooth Muscle-like Cell Differentiation.

Huang HY, Zhang WT, Jiang WY, Chen SZ, Liu Y, Ge X, Li X, Dang YJ, Wen B, Liu XH, Lu HJ, Tang QQ.

J Biol Chem. 2015 Apr 24;290(17):11119-29. doi: 10.1074/jbc.M114.608075. Epub 2015 Mar 16.

6.

BMP4 promotes EMT and mesodermal commitment in human embryonic stem cells via SLUG and MSX2.

Richter A, Valdimarsdottir L, Hrafnkelsdottir HE, Runarsson JF, Omarsdottir AR, Ward-van Oostwaard D, Mummery C, Valdimarsdottir G.

Stem Cells. 2014 Mar;32(3):636-48. doi: 10.1002/stem.1592.

8.

Commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage.

Tang QQ, Otto TC, Lane MD.

Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9607-11. Epub 2004 Jun 21.

9.

Early growth response 2 (Egr2) plays opposing roles in committing C3H10T1/2 stem cells to adipocytes and smooth muscle-like cells.

Wang SS, Huang HY, Chen SZ, Li X, Liu Y, Zhang WT, Tang QQ.

Int J Biochem Cell Biol. 2013 Aug;45(8):1825-32. doi: 10.1016/j.biocel.2013.06.003. Epub 2013 Jun 8.

PMID:
23751188
10.

Retinoic acid inhibits BMP4-induced C3H10T1/2 stem cell commitment to adipocyte via downregulating Smad/p38MAPK signaling.

Lee JS, Park JH, Kwon IK, Lim JY.

Biochem Biophys Res Commun. 2011 Jun 10;409(3):550-5. doi: 10.1016/j.bbrc.2011.05.042. Epub 2011 May 14.

PMID:
21605549
11.

Gdf6 induces commitment of pluripotent mesenchymal C3H10T1/2 cells to the adipocyte lineage.

Wang SS, Huang HY, Chen SZ, Li X, Zhang WT, Tang QQ.

FEBS J. 2013 Jun;280(11):2644-51. doi: 10.1111/febs.12256. Epub 2013 Apr 19.

12.

Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line.

Hamada S, Satoh K, Hirota M, Kimura K, Kanno A, Masamune A, Shimosegawa T.

J Cell Physiol. 2007 Dec;213(3):768-74.

PMID:
17516553
13.

MicroRNA-140 promotes adipocyte lineage commitment of C3H10T1/2 pluripotent stem cells via targeting osteopetrosis-associated transmembrane protein 1.

Liu Y, Zhang ZC, Qian SW, Zhang YY, Huang HY, Tang Y, Guo L, Li X, Tang QQ.

J Biol Chem. 2013 Mar 22;288(12):8222-30. doi: 10.1074/jbc.M112.426163. Epub 2013 Feb 6.

14.

Role of bone morphogenetic protein 4 in the differentiation of brown fat-like adipocytes.

Xue R, Wan Y, Zhang S, Zhang Q, Ye H, Li Y.

Am J Physiol Endocrinol Metab. 2014 Feb 15;306(4):E363-72. doi: 10.1152/ajpendo.00119.2013. Epub 2013 Dec 17.

15.

Inactivation of lysyl oxidase by β-aminopropionitrile inhibits hypoxia-induced invasion and migration of cervical cancer cells.

Yang X, Li S, Li W, Chen J, Xiao X, Wang Y, Yan G, Chen L.

Oncol Rep. 2013 Feb;29(2):541-8. doi: 10.3892/or.2012.2146. Epub 2012 Nov 19.

PMID:
23165370
16.

Lysyl oxidase is associated with the epithelial-mesenchymal transition of gastric cancer cells in hypoxia.

Kasashima H, Yashiro M, Kinoshita H, Fukuoka T, Morisaki T, Masuda G, Sakurai K, Kubo N, Ohira M, Hirakawa K.

Gastric Cancer. 2016 Apr;19(2):431-42. doi: 10.1007/s10120-015-0510-3. Epub 2015 Jun 23.

PMID:
26100130
17.

CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.

Jin L, Chen J, Li L, Li C, Chen C, Li S.

Cell Signal. 2014 Apr;26(4):757-65. doi: 10.1016/j.cellsig.2013.12.017. Epub 2014 Jan 8.

PMID:
24412750
18.

Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.

Shah P, Gau Y, Sabnis G.

Breast Cancer Res Treat. 2014 Jan;143(1):99-111. doi: 10.1007/s10549-013-2784-7. Epub 2013 Dec 5.

PMID:
24305977
19.

Direct transcriptional repression of Zfp423 by Zfp521 mediates a bone morphogenic protein-dependent osteoblast versus adipocyte lineage commitment switch.

Addison WN, Fu MM, Yang HX, Lin Z, Nagano K, Gori F, Baron R.

Mol Cell Biol. 2014 Aug;34(16):3076-85. doi: 10.1128/MCB.00185-14. Epub 2014 Jun 2.

20.

Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.

Toll A, Masferrer E, Hernández-Ruiz ME, Ferrandiz-Pulido C, Yébenes M, Jaka A, Tuneu A, Jucglà A, Gimeno J, Baró T, Casado B, Gandarillas A, Costa I, Mojal S, Peña R, de Herreros AG, García-Patos V, Pujol RM, Hernández-Muñoz I.

J Dermatol Sci. 2013 Nov;72(2):93-102. doi: 10.1016/j.jdermsci.2013.07.001. Epub 2013 Jul 15.

PMID:
23928229

Supplemental Content

Support Center